Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outset Medical (OM) Other Operating Expenses (2019 - 2026)

Outset Medical has reported Other Operating Expenses over the past 7 years, most recently at $12.9 million for Q4 2025.

  • Quarterly Other Operating Expenses fell 7.68% to $12.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.4 million through Dec 2025, down 15.65% year-over-year, with the annual reading at $54.4 million for FY2025, 20.69% down from the prior year.
  • Other Operating Expenses was $12.9 million for Q4 2025 at Outset Medical, down from $13.6 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $25.0 million in Q2 2023 and troughed at $12.9 million in Q4 2025.
  • The 5-year median for Other Operating Expenses is $18.2 million (2024), against an average of $18.5 million.
  • Year-over-year, Other Operating Expenses surged 80.57% in 2021 and then plummeted 43.3% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $23.0 million in 2021, then rose by 2.78% to $23.6 million in 2022, then fell by 6.08% to $22.2 million in 2023, then tumbled by 37.14% to $14.0 million in 2024, then fell by 7.68% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Other Operating Expenses are $12.9 million (Q4 2025), $13.6 million (Q3 2025), and $14.3 million (Q2 2025).